IP Verse

Thermostable Type-A Dna Polymerase Mutants With Increased Polymerization Rate And Resistance To Inhibitors - EP2524036

The patent EP2524036 was granted to Agilent on Jun 12, 2019. The application was originally filed on Aug 2, 2010 under application number EP10805180A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP2524036

AGILENT
Application Number
EP10805180A
Filing Date
Aug 2, 2010
Status
Granted And Under Opposition
May 10, 2019
Publication Date
Jun 12, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

ROCHEMar 12, 2020SIMMONS & SIMMONS MUNICHADMISSIBLE

Patent Citations (10) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS5474920
INTERNATIONAL-SEARCH-REPORTUS2009142754
INTERNATIONAL-SEARCH-REPORTUS2009305292
INTERNATIONAL-SEARCH-REPORTWO2008034110
INTERNATIONAL-SEARCH-REPORTWO2010062777
OPPOSITIONUS2003186238
OPPOSITIONWO0190337
OPPOSITIONWO2005083068
OPPOSITIONWO2010062777
SEARCHWO2008034110

Non-Patent Literature (NPL) Citations (6) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
EXAMINATION- AREZI B ET AL, "Compartmentalized self-replication under fast PCR cycling conditions yields Taq DNA polymerase mutants with increased DNA-binding affinity and blood resistance", vol. 5, doi:10.3389/FMICB.2014.00408, ISSN 1664-302X, pages 1 - 10, FRONTIERS IN MICROBIOLOGY, URL: http://journal.frontiersin.org/article/10.3389/fmicb.2014.00408/abstract, (20140814), XP009187225
OPPOSITION- KERMEKCHIEV et al., "Mutants of Taq DNA polymerase resistant to PCR inhibitors allow DNA amplification from whole blood and crude soil samples", Nucleic Aci ds Res, (20090200), vol. 37, no. 5, page e40, XP002564599
OPPOSITION- WIEDBRAUK et al., "Inhibition of PCR by Aqueous and Vitreous Fluids", J Clin Microbiol, (19950000), vol. 33, pages 2643 - 2646, XP055705259
SEARCH- "Thermus aquaticus DNA polymerase.", Geneseq, (20030717), Database accession no. ABR43331, URL: EBI, XP002722186 [A] 1-15 * the whole document *
SEARCH- MA WU-PO ET AL, "RNA template-dependent 5' nuclease activity of Thermus aquaticus and Thermus thermophilus DNA polymerases", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY, US, (20000811), vol. 275, no. 32, doi:10.1074/JBC.M002268200, ISSN 0021-9258, pages 24693 - 24700, XP002204059 [A] 1-15 * abstract *
SEARCH- KERMEKCHIEV MILKO B ET AL, "Mutants of Taq DNA polymerase resistant to PCR inhibitors allow DNA amplification from whole blood and crude soil samples", NUCLEIC ACIDS RESEARCH, OXFORD : OXFORD UNIV. PRESS, 1974-ANFANGS: LONDON : INFORMATION RETRIEVAL LTD, GB, (20090401), vol. 37, no. 5, doi:10.1093/NAR/GKN1055, ISSN 0305-1048, page E40, XP002564599 [I] 1-3,5-15 * abstract * * figures 4-6 *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents